Rubber Stamp: The FDA Approves Boosters for Young Children Based

Dr. Brian Hooker: "It makes absolutely no sense to approve this particular booster. The trial was so completely small that they could not pick up any type of adverse events that would happen within the population. Testing had no basis in reality regarding the immunogenicity of the vaccine; it had no basis in reality regarding the safety of the vaccine, and then FDA, without convening VRBPAC, goes ahead and approves it anyway."